Yumin Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yumin Choi has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ki Hoon Ahn
Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul, Korea
3 shared publications - Hyeon Ju Shin
Department of Anesthesiology and Pain Medicine, Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea
1 shared publication - Hyung-Jun Lim
Department of Bigdata Convergence, Korea University Graduate School of SW&AI Convergence, Seoul 02841, Republic of Korea
1 shared publication - Hyunyoung Seong
Department of Anesthesiology and Pain Medicine, Anam Hospital, Korea University College of Medicine, Seoul, Republic of Korea
1 shared publication - Jang Wook Sohn
Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea
1 shared publication - Jeong Yeon Kim
Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 18 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (38) , e50463
Explainable artificial intelligence for predicting mortality in geriatric patients undergoing hip arthroplasty
We performed machine learning analysis of population data to determine the major determinants of 1-year mortality among geriatric patients undergoing hip arthroplasty. The data of 17,290 patients aged ≥ 65 years who underwent hip arthroplasty in 2019 were extracted from the Korea National Health Insurance Service claims database. With 1-year mortality as the dependent variable, random forest variable importance and Shapley Additive Explanations (SHAP) were used to identify the major predictors among 31 included predictors and their associations with mortality. The area under the curve of the random forest model was 74.6%. The top 10 predictors were age, red blood cell transfusion, male sex, dementia, low socioeconomic status, presence of solid tumors, history of congestive heart failure, history of chronic kidney disease, statin use, and history of peripheral vascular disease. Univariate analysis and SHAP analysis identified age (maximum SHAP value 0.17), red blood cell transfusion (0.10), male sex (0.09), dementia (0.04), low socioeconomic status (0.03), presence of solid tumors (0.06), history of congestive heart failure (0.04), history of chronic kidney disease (0.05), general anesthesia (0.02), and iron use (0.02) as positive contributors to model predictions of mortality. Higher SHAP values indicate greater contributions to model output relative to the baseline prediction. We constructed an effective prediction model for predicting mortality among patients undergoing hip arthroplasty. Appropriate interventions should be provided for high-risk patients (i.e., advanced age, multiple comorbidities, or anticipated transfusion needs).
- 18 September 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (38) , e50463
Open AccessExplainable artificial intelligence for predicting mortality in geriatric patients undergoing hip arthroplasty
We performed machine learning analysis of population data to determine the major determinants of 1-year mortality among geriatric patients undergoing hip arthroplasty. The data of 17,290 patients aged ≥ 65 years who underwent hip arthroplasty in 2019 were extracted from the Korea National Health Insurance Service claims database. With 1-year mortality as the dependent variable, random forest variable importance and Shapley Additive Explanations (SHAP) were used to identify the major predictors among 31 included predictors and their associations with mortality. The area under the curve of the random forest model was 74.6%. The top 10 predictors were age, red blood cell transfusion, male sex, dementia, low socioeconomic status, presence of solid tumors, history of congestive heart failure, history of chronic kidney disease, statin use, and history of peripheral vascular disease. Univariate analysis and SHAP analysis identified age (maximum SHAP value 0.17), red blood cell transfusion (0.10), male sex (0.09), dementia (0.04), low socioeconomic status (0.03), presence of solid tumors (0.06), history of congestive heart failure (0.04), history of chronic kidney disease (0.05), general anesthesia (0.02), and iron use (0.02) as positive contributors to model predictions of mortality. Higher SHAP values indicate greater contributions to model output relative to the baseline prediction. We constructed an effective prediction model for predicting mortality among patients undergoing hip arthroplasty. Appropriate interventions should be provided for high-risk patients (i.e., advanced age, multiple comorbidities, or anticipated transfusion needs).
- Open Access
- 2 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (23) , 7327
Blood Transfusion Utilization in Patients with Severe Coronavirus Disease 2019 in the Republic of Korea: A Nationwide Population-Based Study
Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly affected both supply and demand for blood transfusion. This study aimed to investigate the prescription patterns of blood products and identify the risk factors for blood transfusion in patients with severe COVID-19. Methods: This nationwide population-based cohort study was performed in the Republic of Korea between January 2021 and December 2021. Adult patients (≥19 years) with severe COVID-19 who received oxygen therapy were examined. Data were obtained from the National Health Insurance Service database. Results: During the study period, 41,203 patients developed severe COVID-19. The overall transfusion rate was 7.11%, with 14,477 units of packed red blood cells, 4501 units of fresh frozen plasma, 20,532 units of platelet concentrates, and 1875 units of cryoprecipitate. Blood transfusion was independently associated with 90-day mortality (hazard ratio: 1.36, 95% confidence interval: 1.21–1.53, p < 0.001). Multivariate logistic regression analysis identified underlying chronic kidney disease; exposure to surgery, thrombolysis, or thrombectomy; renal replacement therapy; mechanical ventilation; and extracorporeal membrane oxygenation as significant risk factors for blood transfusion in patients with severe COVID-19. Conversely, underlying cerebrovascular diseases, a Charlson Comorbidity Index score of ≥6, admission to intensive care units, and anticoagulant use were identified as protective factors. Conclusions: This study provides an overview of blood transfusion patterns in patients with severe COVID-19. Understanding these patterns may help optimize the stockpiling of medical resources.
- 2 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (23) , 7327
Open AccessBlood Transfusion Utilization in Patients with Severe Coronavirus Disease 2019 in the Republic of Korea: A Nationwide Population-Based Study
Background: The coronavirus disease 2019 (COVID-19) pandemic has significantly affected both supply and demand for blood transfusion. This study aimed to investigate the prescription patterns of blood products and identify the risk factors for blood transfusion in patients with severe COVID-19. Methods: This nationwide population-based cohort study was performed in the Republic of Korea between January 2021 and December 2021. Adult patients (≥19 years) with severe COVID-19 who received oxygen therapy were examined. Data were obtained from the National Health Insurance Service database. Results: During the study period, 41,203 patients developed severe COVID-19. The overall transfusion rate was 7.11%, with 14,477 units of packed red blood cells, 4501 units of fresh frozen plasma, 20,532 units of platelet concentrates, and 1875 units of cryoprecipitate. Blood transfusion was independently associated with 90-day mortality (hazard ratio: 1.36, 95% confidence interval: 1.21–1.53, p < 0.001). Multivariate logistic regression analysis identified underlying chronic kidney disease; exposure to surgery, thrombolysis, or thrombectomy; renal replacement therapy; mechanical ventilation; and extracorporeal membrane oxygenation as significant risk factors for blood transfusion in patients with severe COVID-19. Conversely, underlying cerebrovascular diseases, a Charlson Comorbidity Index score of ≥6, admission to intensive care units, and anticoagulant use were identified as protective factors. Conclusions: This study provides an overview of blood transfusion patterns in patients with severe COVID-19. Understanding these patterns may help optimize the stockpiling of medical resources.
- Open Access
Explainable Model Using Shapley Additive Explanations Approach on Wound Infection after Wide Soft Tissue Sarcoma Resection: “Big Data” Analysis Based on Health Insurance Review and Assessment Service Hub
Background and Objectives: Soft tissue sarcomas represent a heterogeneous group of malignant mesenchymal tissues. Despite their low prevalence, soft tissue sarcomas present clinical challenges for orthopedic surgeons owing to their aggressive nature, and perioperative wound infections. However, the low prevalence of soft tissue sarcomas has hindered the availability of large-scale studies. This study aimed to analyze wound infections after wide resection in patients with soft tissue sarcomas by employing big data analytics from the Hub of the Health Insurance Review and Assessment Service (HIRA). Materials and Methods: Patients who underwent wide excision of soft tissue sarcomas between 2010 and 2021 were included. Data were collected from the HIRA database of approximately 50 million individuals’ information in the Republic of Korea. The data collected included demographic information, diagnoses, prescribed medications, and surgical procedures. Random forest has been used to analyze the major associated determinants. A total of 10,906 observations with complete data were divided into training and validation sets in an 80:20 ratio (8773 vs. 2193 cases). Random forest permutation importance was employed to identify the major predictors of infection and Shapley Additive Explanations (SHAP) values were derived to analyze the directions of associations with predictors. Results: A total of 10,969 patients who underwent wide excision of soft tissue sarcomas were included. Among the study population, 886 (8.08%) patients had post-operative infections requiring surgery. The overall transfusion rate for wide excision was 20.67% (2267 patients). Risk factors among the comorbidities of each patient with wound infection were analyzed and dependence plots of individual features were visualized. The transfusion dependence plot reveals a distinctive pattern, with SHAP values displaying a negative trend for individuals without blood transfusions and a positive trend for those who received blood transfusions, emphasizing the substantial impact of blood transfusions on the likelihood of wound infection. Conclusions: Using the machine learning random forest model and the SHAP values, the perioperative transfusion, male sex, old age, and low SES were important features of wound infection in soft-tissue sarcoma patients.
Open AccessExplainable Model Using Shapley Additive Explanations Approach on Wound Infection after Wide Soft Tissue Sarcoma Resection: “Big Data” Analysis Based on Health Insurance Review and Assessment Service Hub
Background and Objectives: Soft tissue sarcomas represent a heterogeneous group of malignant mesenchymal tissues. Despite their low prevalence, soft tissue sarcomas present clinical challenges for orthopedic surgeons owing to their aggressive nature, and perioperative wound infections. However, the low prevalence of soft tissue sarcomas has hindered the availability of large-scale studies. This study aimed to analyze wound infections after wide resection in patients with soft tissue sarcomas by employing big data analytics from the Hub of the Health Insurance Review and Assessment Service (HIRA). Materials and Methods: Patients who underwent wide excision of soft tissue sarcomas between 2010 and 2021 were included. Data were collected from the HIRA database of approximately 50 million individuals’ information in the Republic of Korea. The data collected included demographic information, diagnoses, prescribed medications, and surgical procedures. Random forest has been used to analyze the major associated determinants. A total of 10,906 observations with complete data were divided into training and validation sets in an 80:20 ratio (8773 vs. 2193 cases). Random forest permutation importance was employed to identify the major predictors of infection and Shapley Additive Explanations (SHAP) values were derived to analyze the directions of associations with predictors. Results: A total of 10,969 patients who underwent wide excision of soft tissue sarcomas were included. Among the study population, 886 (8.08%) patients had post-operative infections requiring surgery. The overall transfusion rate for wide excision was 20.67% (2267 patients). Risk factors among the comorbidities of each patient with wound infection were analyzed and dependence plots of individual features were visualized. The transfusion dependence plot reveals a distinctive pattern, with SHAP values displaying a negative trend for individuals without blood transfusions and a positive trend for those who received blood transfusions, emphasizing the substantial impact of blood transfusions on the likelihood of wound infection. Conclusions: Using the machine learning random forest model and the SHAP values, the perioperative transfusion, male sex, old age, and low SES were important features of wound infection in soft-tissue sarcoma patients.